Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Cantor Fitzgerald
Fuji
Citi
Covington
Argus Health
US Army
US Department of Justice
UBS

Generated: December 19, 2018

DrugPatentWatch Database Preview

Drug Price Trends for MUPIROCIN

« Back to Dashboard

Drug Price Trends for MUPIROCIN

Average Pharmacy Cost for MUPIROCIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
MUPIROCIN 2% OINTMENT 00168-0352-22 0.19661 GM 2018-11-21
MUPIROCIN 2% OINTMENT 68462-0180-22 0.19661 GM 2018-11-21
MUPIROCIN 2% OINTMENT 45802-0112-22 0.19661 GM 2018-11-21
MUPIROCIN 2% CREAM 68462-0564-17 10.83656 GM 2018-11-21
MUPIROCIN 2% OINTMENT 00093-1010-42 0.19661 GM 2018-11-21
MUPIROCIN 2% CREAM 68462-0564-35 8.62885 GM 2018-11-21
MUPIROCIN 2% OINTMENT 51672-1312-00 0.19661 GM 2018-11-21
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for MUPIROCIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
MUPIROCIN 2% OINT,TOP Perrigo Sourcing Solutions, Inc. 45802-0112-22 22GM 2.59 0.11773 GM 2018-10-01 - 2023-09-30 FSS
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Healthtrust
Dow
Baxter
Cantor Fitzgerald
Chubb
Medtronic
Julphar
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.